Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $19.00.

Charting, Price Performance, News & Related Contracts.

This U.S. ETF only holds stocks that have increased dividends for 25+ consecutive years. The post 1 “Growthy” Dividend ETF to Buy to Generate Passive Income appeared first on The Motley Fool Canada.